123 related articles for article (PubMed ID: 3261688)
21. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.
Russell ME; Quertermous T; Declerck PJ; Collen D; Haber E; Homcy CJ
J Biol Chem; 1990 Feb; 265(5):2569-75. PubMed ID: 2105930
[TBL] [Abstract][Full Text] [Related]
22. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
Hekman CM; Loskutoff DJ
Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
[TBL] [Abstract][Full Text] [Related]
23. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
Wun TC; Palmier MO; Siegel NR; Smith CE
J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
[TBL] [Abstract][Full Text] [Related]
24. Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation.
Katagiri K; Okada K; Hattori H; Yano M
Eur J Biochem; 1988 Sep; 176(1):81-7. PubMed ID: 3262060
[TBL] [Abstract][Full Text] [Related]
25. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.
Hekman CM; Loskutoff DJ
J Biol Chem; 1985 Sep; 260(21):11581-7. PubMed ID: 3930479
[TBL] [Abstract][Full Text] [Related]
26. Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cells.
Booyse FM; Scheinbuks J; Lin PH; Traylor M; Bruce R
J Biol Chem; 1988 Oct; 263(29):15129-38. PubMed ID: 3139666
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
Reilly TM; Seetharam R; Duke JL; Davis GL; Pierce SK; Walton HL; Kingsley D; Sisk WP
J Biol Chem; 1990 Jun; 265(16):9570-4. PubMed ID: 2188980
[TBL] [Abstract][Full Text] [Related]
28. Purification and characterisation of plasminogen activator inhibitor 2 produced in Saccharomyces cerevisiae.
Steven J; Cottingham IR; Berry SJ; Chinery SA; Goodey AR; Courtney M; Ballance DJ
Eur J Biochem; 1991 Mar; 196(2):431-8. PubMed ID: 1901039
[TBL] [Abstract][Full Text] [Related]
29. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
Schleef RR; Bevilacqua MP; Sawdey M; Gimbrone MA; Loskutoff DJ
J Biol Chem; 1988 Apr; 263(12):5797-803. PubMed ID: 3128548
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma.
Wiman B; Almquist A; Sigurdardottir O; Lindahl T
FEBS Lett; 1988 Dec; 242(1):125-8. PubMed ID: 2462509
[TBL] [Abstract][Full Text] [Related]
32. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
[TBL] [Abstract][Full Text] [Related]
33. Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasma.
Alessi MC; Juhan-Vague I; Declerck PJ; Collen D
Thromb Res; 1991 May; 62(4):275-85. PubMed ID: 1907771
[TBL] [Abstract][Full Text] [Related]
34. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
[TBL] [Abstract][Full Text] [Related]
35. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
Ehrlich HJ; Gebbink RK; Preissner KT; Keijer J; Esmon NL; Mertens K; Pannekoek H
J Cell Biol; 1991 Dec; 115(6):1773-81. PubMed ID: 1721912
[TBL] [Abstract][Full Text] [Related]
36. Purification of storage granule protein-23. A novel protein identified by phage display technology and interaction with type I plasminogen activator inhibitor.
Lang IM; Chuang TL; Barbas CF; Schleef RR
J Biol Chem; 1996 Nov; 271(47):30126-35. PubMed ID: 8939962
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator inhibitor type 1 production by rat type II pneumocytes in culture.
Parton LA; Warburton D; Laug WE
Am J Respir Cell Mol Biol; 1992 Feb; 6(2):133-9. PubMed ID: 1540377
[TBL] [Abstract][Full Text] [Related]
38. Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.
Zeheb R; Rafferty UM; Rodriguez MA; Andreasen P; Gelehrter TD
Thromb Haemost; 1987 Dec; 58(4):1017-23. PubMed ID: 3127913
[TBL] [Abstract][Full Text] [Related]
39. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
[TBL] [Abstract][Full Text] [Related]
40. Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C.
Fay WP; Owen WG
Biochemistry; 1989 Jul; 28(14):5773-8. PubMed ID: 2505842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
